Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study

被引：0
|
作者：
Calabrese, Joseph [1 ]
Sanchez, Raymond [1 ]
Jin, Na [1 ]
Amatniek, Joan [1 ]
Cox, Kevin [1 ]
Johnson, Brian [1 ]
Perry, Pamela P. [1 ]
Hertel, Peter [1 ]
Such, Pedro [1 ]
Salzman, Phyllis M. [1 ]
McQuade, Robert D. [1 ]
Nyilas, Margaretta [1 ]
Carson, William H. [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2016年 / 41卷
关键词：
Bipolar I Disorder; Aripiprazole Once-Monthly; Maintenance Treatment; Long-Acting Injectable Antipsychotic;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T116
引用
收藏
页码：S360 / S361
页数：2
相关论文
共 50 条
  • [21] A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder
    Zhang, Ling
    Zhang, Honggeng
    Lv, Lu-xian
    Tan, Qingrong
    Xu, Xiufeng
    Hu, Jian
    Zi, Lu
    Cooper, James
    Phansalkar, Abhay
    Wang, Gang
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2022, 10 (01)
  • [22] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, R.
    Loebel, A.
    Phillips, D.
    Pikalov, A.
    Hernandez, D.
    Mao, Y.
    Cucchiaro, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 153 - 154
  • [23] A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY OF LURASIDONE FOR THE MAINTENANCE OF EFFICACY IN PATIENTS WITH SCHIZOPHRENIA
    Tandon, Rajiv
    Loebel, Antony
    Phillips, Debra
    Pikalov, Andrei
    Hernandez, David
    Mao, Yongcai
    Cucchiaro, Josephine
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S372 - S372
  • [24] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, Rajiv
    Cucchiaro, Josephine
    Phillips, Debra
    Hernandez, David
    Mao, Yongcai
    Pikalov, Andrei
    Loebel, Antony
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (01) : 69 - 77
  • [25] A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY OF LURASIDONE FOR THE MAINTENANCE OF EFFICACY IN PATIENTS WITH SCHIZOPHRENIA
    Tandon, R.
    Loebel, A.
    Phillips, D.
    Pikalov, A.
    Hernandez, D.
    Mao, Y.
    Cucchiaro, J.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [26] Efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
    Ebrecht, M.
    Sickmann, V
    Kungel, M.
    Werner, C.
    Marcus, R.
    McQuade, R.
    Modell, S.
    PHARMACOPSYCHIATRY, 2007, 40 (05) : 207 - 207
  • [27] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
    Berman, Robert M.
    Marcus, Ronald N.
    Swanink, Rene
    McQuade, Robert D.
    Carson, William H.
    Corey-Lisle, Patricia K.
    Khan, Arif
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) : 843 - 853
  • [28] Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism - A double-blind placebo-controlled study
    Salloum, IM
    Cornelius, JR
    Daley, DC
    Kirisci, L
    Himmelhoch, JM
    Thase, ME
    ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (01) : 37 - 45
  • [29] A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder
    Bowden, CL
    Grunze, H
    Mullen, J
    Brecher, M
    Paulsson, B
    Jones, M
    Vågerö, M
    Svensson, K
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (01) : 111 - 121
  • [30] Safety and Effectiveness of Aripiprazole Once-monthly for the Treatment of Schizophrenia: A Pooled Analysis of Two Double-blind, Randomized, Controlled Trials (246 and 247)
    Fleischhacker, W. Wolfgang
    Sanchez, Raymond
    Lan-Feng, Tsai
    Peters-Strickland, Timothy
    Baker, Ross A.
    Eramo, Anna
    Kostic, Dusan
    Kane, John
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S394 - S395
12345